skip to main content

Post-MI secondary prevention — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsPost-MI secondary preventionGPhC CRA

A man is discharged after MI on aspirin, ticagrelor, ramipril and bisoprolol, but no statin is listed. He has no statin intolerance. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Query omission of high-intensity statin therapy

This scenario assesses Post-MI secondary prevention in a UK pharmacy practice context. High-intensity statin therapy is standard secondary prevention after acute coronary syndrome unless contraindicated. The best answer is Query omission of high-intensity statin therapy because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: NICE CKS; BNF